AU470631B2 - Tertiary alcohol stabilized e-series prostaglandins - Google Patents

Tertiary alcohol stabilized e-series prostaglandins

Info

Publication number
AU470631B2
AU470631B2 AU79877/75A AU7987775A AU470631B2 AU 470631 B2 AU470631 B2 AU 470631B2 AU 79877/75 A AU79877/75 A AU 79877/75A AU 7987775 A AU7987775 A AU 7987775A AU 470631 B2 AU470631 B2 AU 470631B2
Authority
AU
Australia
Prior art keywords
tertiary alcohol
series prostaglandins
alcohol stabilized
stabilized
prostaglandins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU79877/75A
Other languages
English (en)
Other versions
AU7987775A (en
Inventor
Charles Monkhouse Donald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of AU470631B2 publication Critical patent/AU470631B2/en
Publication of AU7987775A publication Critical patent/AU7987775A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
AU79877/75A 1974-04-19 1975-04-07 Tertiary alcohol stabilized e-series prostaglandins Expired AU470631B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US462213A US3927197A (en) 1974-04-19 1974-04-19 Tertiary alcohol stabilized E-series prostaglandins
USUS462,213 1974-04-19

Publications (2)

Publication Number Publication Date
AU470631B2 true AU470631B2 (en) 1976-03-25
AU7987775A AU7987775A (en) 1976-03-25

Family

ID=23835600

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79877/75A Expired AU470631B2 (en) 1974-04-19 1975-04-07 Tertiary alcohol stabilized e-series prostaglandins

Country Status (23)

Country Link
US (1) US3927197A (US07166745-20070123-C00016.png)
JP (1) JPS5337408B2 (US07166745-20070123-C00016.png)
AR (1) AR213271A1 (US07166745-20070123-C00016.png)
AT (1) AT348130B (US07166745-20070123-C00016.png)
AU (1) AU470631B2 (US07166745-20070123-C00016.png)
BE (1) BE828065A (US07166745-20070123-C00016.png)
BG (1) BG35326A3 (US07166745-20070123-C00016.png)
CA (1) CA1034044A (US07166745-20070123-C00016.png)
CS (1) CS191244B2 (US07166745-20070123-C00016.png)
DD (1) DD119131A5 (US07166745-20070123-C00016.png)
DE (1) DE2516105C3 (US07166745-20070123-C00016.png)
DK (1) DK138161B (US07166745-20070123-C00016.png)
ES (1) ES436613A1 (US07166745-20070123-C00016.png)
FI (1) FI62220C (US07166745-20070123-C00016.png)
FR (1) FR2267760B1 (US07166745-20070123-C00016.png)
GB (1) GB1474852A (US07166745-20070123-C00016.png)
HU (1) HU175405B (US07166745-20070123-C00016.png)
IE (1) IE40829B1 (US07166745-20070123-C00016.png)
IL (1) IL46994A (US07166745-20070123-C00016.png)
LU (1) LU72320A1 (US07166745-20070123-C00016.png)
NL (1) NL158384B (US07166745-20070123-C00016.png)
PH (1) PH11697A (US07166745-20070123-C00016.png)
SE (1) SE428528B (US07166745-20070123-C00016.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197257A (en) * 1976-02-04 1980-04-08 The Upjohn Company 6-Keto prostaglandin derivatives
US4169895A (en) * 1976-09-28 1979-10-02 Pfizer Inc. Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4098805A (en) * 1977-04-11 1978-07-04 The Upjohn Company 9-deoxy-9-methylene-pgf-type amides
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
ZA837627B (en) * 1982-10-15 1984-06-27 Procter & Gamble Storage stable topical pharmaceutical composition containing low dielectric solvents
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
ES2142409T3 (es) * 1993-10-27 2000-04-16 Upjohn Co Prostaglandina e 1 estabilizada.
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
US20050203086A1 (en) * 2004-03-04 2005-09-15 Pfizer Inc. Methods of treatment using an EP2 selective receptor agonist
US20100099640A1 (en) * 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
AT515356B1 (de) * 2014-01-30 2015-11-15 Gebro Holding Gmbh Stabile alkoholische Lösung von Alprostadil
RU2020130837A (ru) 2018-02-21 2022-03-21 ЭйАй ТЕРАПЬЮТИКС, ИНК. Комбинационная терапия апилимодом и глутаматергическими агентами

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
US3749800A (en) * 1971-11-01 1973-07-31 Upjohn Co Stable composition for dispensing pge2
US3833725A (en) * 1972-12-08 1974-09-03 Syntex Corp Dialkylated glycol compositions and medicament preparations containing same

Also Published As

Publication number Publication date
LU72320A1 (US07166745-20070123-C00016.png) 1976-03-17
PH11697A (en) 1978-05-24
JPS5337408B2 (US07166745-20070123-C00016.png) 1978-10-09
IE40829B1 (en) 1979-08-29
CS191244B2 (en) 1979-06-29
ES436613A1 (es) 1977-04-16
FI751108A (US07166745-20070123-C00016.png) 1975-10-20
SE428528B (sv) 1983-07-11
DK138161B (da) 1978-07-24
SE7503723L (sv) 1975-10-20
IL46994A0 (en) 1975-06-25
AT348130B (de) 1979-01-25
ATA278875A (de) 1978-06-15
US3927197A (en) 1975-12-16
AR213271A1 (es) 1979-01-15
DE2516105A1 (de) 1975-10-23
GB1474852A (en) 1977-05-25
BE828065A (fr) 1975-10-17
DK167075A (US07166745-20070123-C00016.png) 1975-10-20
JPS50145515A (US07166745-20070123-C00016.png) 1975-11-21
NL7504274A (nl) 1975-10-21
NL158384B (nl) 1978-11-15
CA1034044A (en) 1978-07-04
DE2516105B2 (de) 1981-01-08
IL46994A (en) 1979-10-31
FR2267760A1 (US07166745-20070123-C00016.png) 1975-11-14
BG35326A3 (en) 1984-03-15
FR2267760B1 (US07166745-20070123-C00016.png) 1978-08-04
IE40829L (en) 1975-10-19
HU175405B (hu) 1980-07-28
DE2516105C3 (de) 1982-01-07
FI62220C (fi) 1982-12-10
FI62220B (fi) 1982-08-31
DD119131A5 (US07166745-20070123-C00016.png) 1976-04-12
AU7987775A (en) 1976-03-25
DK138161C (US07166745-20070123-C00016.png) 1979-01-02

Similar Documents

Publication Publication Date Title
CA1030662A (en) Capacitive circuitboard
CA1034044A (en) Tertiary alcohol stabilized e-series prostaglandins
AU8652675A (en) Piston
AU501389B2 (en) Prostaglandin analogues
CA1025259A (en) Mold construction
CA1009478A (en) Connecting rod assembly
AU497401B2 (en) Prostaglandin compositions
AU499372B2 (en) Benzofuran compounds
AU497823B2 (en) Low pressure casting
AU502576B2 (en) 11-deoxy prostaglandins
AU493932B2 (en) Novel prostaglandins
CA1022434A (en) Actuator
AU498953B2 (en) Alcohol separation
SU601500A1 (ru) Поршень
AU8609275A (en) Cistern
CA1031334A (en) Prostaglandins
AU491252B1 (en) Piston
AU489183B1 (en) Cistern
CA1002930A (en) Linear actuator
AU8736275A (en) 11-desocy-15-substituted-w-pentanor prostaglandins
AU470751B2 (en) Novel carbonyl compounds
AU493174B2 (en) Precision current-source arrangement
AU518771B2 (en) Producing 1-carboxymethyl-5-mercaptotetrazole
CA991867A (en) Movable wall for engine nozzle
AU481402B2 (en) Linear actuator